SYNGR2 and cancer: Taking into account the lack of normal samples in the TCGA database for some cancer types, we integrated the GTEx database for further analysis and the results showed that the expression level of SYNGR2 in most tumor tissues are much higher than the corresponding control tissues (Fig. 2B).